Lundekvam JA, Høivik ML, Anisdahl K, Småstuen MC, Warren DJ, Bolstad N, Medhus AW(2025) Tumour necrosis factor inhibitors in Ulcerative colitis: real-world data on Therapeutic drug monitoring and evaluation of current treatment targets (STRIDE II) Ann Med, 57(1), 2424447 DOI 10.1080/07853890.2024.2424447, PubMed 39757985
Olsen BC, Opheim R, Kristensen VA, Høivik ML, Lund C, Aabrekk TB, Johansen I, Aass Holten KI, Strande V, Glad IF, Bengtson MB, Ricanek P, Detlie TE, Medhus AW, Boyar R, Torp R, Vatn S, Frigstad SO, Valeur J, Bernklev T, Jelsness-Jørgensen LP, Huppertz-Hauss G(2025) Prevalence of Irritable Bowel Syndrome Based on Rome IV Criteria in Patients in Biochemical and Endoscopic Remission From Newly Diagnosed Inflammatory Bowel Disease: One- and Three-Year Results (the IBSEN III Cohort) Inflamm Bowel Dis(in press) DOI 10.1093/ibd/izaf047, PubMed 40063582
